# Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment

> **NCT06773117** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Tasly Pharmaceutical Group Co., Ltd** · enrollment: 360 (estimated)

## Conditions studied

- Cough

## Interventions

- **DRUG:** Susu Xiao'er Zhike Granules
- **DRUG:** Extremely-low dose Susu Xiao'er Zhike Granules

## Key facts

- **NCT ID:** NCT06773117
- **Lead sponsor:** Tasly Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06773117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06773117, "Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06773117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*